Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 216-653-1 | CAS number: 1634-04-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Investigators report, produced as a part of Health Effects Institue Research Report 102; well-conducted and documented study, adequate for assessment.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 001
Materials and methods
- Objective of study:
- metabolism
- Principles of method if other than guideline:
- 4 hours exposure of rats to 2 concentrations of MTBE vapour, followed by quantification of MTBE and its metabolites in blood and urine.
- GLP compliance:
- not specified
Test material
- Reference substance name:
- tert-butyl methyl ether
- EC Number:
- 216-653-1
- EC Name:
- tert-butyl methyl ether
- Cas Number:
- 1634-04-4
- Molecular formula:
- C5H12O
- IUPAC Name:
- 2-methoxy-2-methylpropane
- Details on test material:
- - Name of test material (as cited in study report): MTBE
- Analytical purity: > 99.8%
- Supplier: Aldrich Chemical Company (Deisenhofen, Germany).
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan Winkelmann, Borchen, Germany
- Age at study initiation: 12 weeks
- Weight at study initiation: 210-240 g (males); 190-220 g (females)
- Fasting period before study:
- Housing: during the exposure: separate Macrolon cages; after the exposure metabolic cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 3 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation: vapour
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- TYPE OF INHALATION EXPOSURE: whole body
GENERATION OF TEST ATMOSPHERE / CHAMPER DESCRIPTION
- Exposure apparatus: dynamic exposure chamber, total volume 8 m3
- Method of holding animals in test chamber: caged
- Rate of air: 28 m3/hour
- Temperature: 22 °C
- humidity: 50-60% - Duration and frequency of treatment / exposure:
- 4 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
4 and 40 ppm
- No. of animals per sex per dose / concentration:
- 5/sex/dose
- Control animals:
- no
- Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled : urine, blood
- Time and frequency of sampling: urine was collected at 4 °C for 72 h at 6-h intervals. Blood samples were taken at the end of the exposure.
- Other:
METABOLITE CHARACTERISATION STUDIES
- Tissues and body fluids sampled: urine, blood
- Method type(s) for identification: GC-MS - Statistics:
- Statistical analysis were performed using a Student t test. To determine possible sex differences, all data from the male and female animals were compared using a t test. P values of < 0.05 were considered significant. Half-times were calculated using exponential regression in Excel. The curve-fitting function of the program was used, and curves were stripped based on correlation coefficients. All correlation values (r2) > 0.95 were considered for separation.
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- The concentrations of MTBE in rat blood immediately after the end of exposure to 4 and 40 ppm MTBE were 2.3 ± 1.0 and 5.9 ± 1.8 μM, respectively.
Besides MTBE, tert-butyl alcohol (TBA) was also detected in blood of the rats after the end of exposure at concentrations 2.9 ± 0.5 and 36.7 ± 10.8 μM, respectively.
TBA was also detected in low concentrations in blood samples taken from control rats; however, blood samples taken from rats after exposure to 4 ppm showed statistically significant increases in TBA concentrations at the end of exposure. - Details on distribution in tissues:
- No data.
- Details on excretion:
- MTBE was cleared from blood with a half-time of 30 minutes. No sex differences in the apparent elimination half-times were found.
In rat urine, the ether concentrations were already below the limit of detection in the first available samples (6 h after the end of exposure). The rate of excretion of MTBE metabolites in rat urine was slower compared to exhaled breath. All MTBE metabolites were eliminated with apparent half-times of elimination of less than 5 h.
Toxicokinetic parameters
- Test no.:
- #1
- Toxicokinetic parameters:
- half-life 1st: 0.5 ± 0.2 h
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- TBA, 2-methyl-1,2-propanediol, and 2-hydroxyisobutyrate are MTBE metabolites excreted in urine. Based on the confirmed structures of the metabolites, MTBE biotransformation proceeds by oxidation of the methyl group in MTBE to give an intermediate hemiacetal, which decomposes with release of formaldehyde to TBA.
Any other information on results incl. tables
Formation of the other MTBE metabolites involves further biotransformation of TBA formed in the first step of metabolic pathway. Conjugation of TBA with activated glucuronic acid results in excretion of the glucuronide conjugate. The two other metabolites (2-methyl-1,2-propanediol and 2-hydroxyisobutyrate) present in urine of TBA-treated animals and also in urine of rats exposed to MTBE suggest further oxidative metabolism of the intermediate metabolite TBA. The likely pathway for formation of these metabolites involves oxidation of TBA by CYP to give 2-methyl-1,2-propanediol. TBA is not a substrate for alcohol dehydrogenase, but it is oxidized by rat liver microsomes to formaldehyde and acetone under conditions consistent with an involvement of CYP (Cederbaum and Cohen 1980, Cederbaum et al 1983). CYPmediated oxidation of a C–H bond in one of the methyl groups of TBA results in excretion of the diol metabolite. Further oxidation of 2-methyl-1,2-propanediol results in 2-hydroxyisobutyrate, which is excreted as a major metabolite of TBA, as well as of MTBE.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.